Biotech Manufacturing Grows Up

Biotech Manufacturing Grows Up

In addition to the inherent difficulties associated with a production platform based on molecular and cellular biology, biopharmaceutical manufacturing always has been subject to the vicissitudes of unpredictable clinical trials, regulatory requirements, product approvals, and market demand. In the...

Full description

Saved in:
Bibliographic Details
Published in:Biopharm International Vol. 20; no. 10; p. 159
Main Authors: Kamarck, Michael E, Hann, Louane E, Adamson, S Robert
Format: Trade Publication Article
Language:English
Published: Monmouth Junction MultiMedia Healthcare Inc 01-10-2007
Subjects:
Biology
Biotechnology industry
Capital investments
Cellular biology
Chemical compounds
Clinical trials
Costs
Drugs
Growth hormones
Hemophilia
Intellectual property
Manufacturing
Manufacturing cells
Monoclonal antibodies
Outsourcing
Pharmaceutical industry
Product development
Productivity
Proteins
Regulatory agencies
Regulatory approval
Rheumatoid arthritis
Stainless steel
Standardization
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In addition to the inherent difficulties associated with a production platform based on molecular and cellular biology, biopharmaceutical manufacturing always has been subject to the vicissitudes of unpredictable clinical trials, regulatory requirements, product approvals, and market demand. In the future, we will see other major pharmaceutical and biotechnology companies increase their manufacturing capacity and flexibility through the use of improved biological expression systems, innovative process technologies, optimized workflows, and standardization, all without having to invest in additional stainless steel.
ISSN:1542-166X
1939-1862